BESSEMER GROUP INC - GLOBAL BLOOD THERAPEUTICS IN ownership

GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 233 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q4 2020. The put-call ratio across all filers is 1.21 and the average weighting 0.2%.

Quarter-by-quarter ownership
BESSEMER GROUP INC ownership history of GLOBAL BLOOD THERAPEUTICS IN
ValueSharesWeighting
Q1 2022$6,000
+20.0%
1600.0%0.00%
Q4 2021$5,000
+25.0%
1600.0%0.00%
Q3 2021$4,000
-33.3%
1600.0%0.00%
Q2 2021$6,000
-14.3%
1600.0%0.00%
Q1 2021$7,000
-68.2%
160
-68.0%
0.00%
Q4 2020$22,000
-38.9%
500
-23.1%
0.00%
Q3 2020$36,000
-42.9%
650
-35.0%
0.00%
Q2 2020$63,000
-95.9%
1,000
-98.0%
0.00%
-100.0%
Q3 2017$1,553,000
+13.5%
50,0090.0%0.01%0.0%
Q2 2017$1,368,000
+308.4%
50,009
+115.9%
0.01%
+200.0%
Q4 2016$335,00023,1600.00%
Other shareholders
GLOBAL BLOOD THERAPEUTICS IN shareholders Q4 2020
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 595,473$25,790,0004.19%
Grace Capital 131,549$5,697,0003.60%
Fernwood Investment Management, LLC 201,657$8,734,0003.44%
Fairmount Funds Management LLC 215,000$9,312,0003.33%
Arctis Global LLC 293,700$12,720,0002.74%
Perceptive Advisors 5,674,711$245,771,0002.64%
ArchPoint Investors 217,510$9,420,0002.61%
Alerce Investment Management, L.P. 126,270$5,469,0002.15%
Profit Investment Management, LLC 42,196$1,826,0001.17%
Affinity Asset Advisors, LLC 50,000$2,166,0001.15%
View complete list of GLOBAL BLOOD THERAPEUTICS IN shareholders